Breaking News

Cube Biotech Acquires IBA Lifesciences

Combines Cube Biotech’s protein technologies with IBA's high-performance research tools for protein isolation and analysis.

Author Image

By: Charlie Sternberg

Associate Editor

Cube Biotech and IBA Lifesciences, two innovators in the biotechnology industry, have merged to create a unified entity dedicated to advancing research and production capabilities for the life science industry. The combined company will leverage its complementary strengths to deliver solutions in protein purification and stabilization and to enable research in the field of challenging drug targets. By combining Cube Biotech’s expertise in protein technologies with IBA Lifesciences strength...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters